Study of Dextromethorphan in OCD and Related Disorders
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in
combination with fluoxetine for symptom relief in OCD and related disorders.